#IDtwitter

So here’s a question. What happens once the 1st drug is shown in RCT to be effective vs COVID? Say, Remdesevir in upcoming Chinese data. So that’s the standard of

1/ Two years of ID fellowship and here's what I've learnt. 1. You can never read enough. So keep reading.2. Experience > knowledge but knowledge adds to experience 3. Pay

Ilan Schwartz MD PhD

A telltale sign of #COVID19: pernio / pseudo-chilblains Painful, swollen and erythematous tips of toes (resembling frostbite).#DermTwitter #IDTwitter https://twitter.com/dwahezi/status/1248804396470804481?s=21 https://twitter.com/dwahezi/status/12488

Christopher Graber

OK, #IDTwitter, we need to talk about y’all’s bashing of the @nejm remdesivir paper.We all want RCTs, but the data collection for this paper started in JANUARY. I didn’t know

BIDMC Infectious Diseases Fellowship

BIDMC_IDFellows

Fri AM ID Fellow Conference! The amazing @_CatherineLi, PharmD chatting about Cdiff!! Join us and comment on some highlights! #IDTwitter #MedTwitter #tweetorial #IDMedEd What is Cdiff doing in the US?Did

Jonathan Ryder, MD

JonathanRyderMD

Random thought experiment of the day (brought on by HCQ discussions):In criminal law, the burden of proof lies on the government. The defendant is innocent until proven guilty, rather than

Matthew Katz, MD

If you're interested to see what infectious disease specialists are saying, here are 300+ of them. @DrJRMarcelin @GermHunterMD @jdcooperid please let me know if I am missing anyone #IDTwitter https://twitter.com/i/lists/1238765369768148992/member

Megan L. Srinivas, MD MPH

Dear friends and neighbors,How does a face shield work versus a face mask?Wearing PPE in public is one of the only tools we have right now to mitigate transmission while

EpidemioLakshmy

epidemiolakshmy

@SaskiaPopescu @aetiology @angievassallo @angie_rasmussen, as we do #scicomm on transmission of respiratory infections, I came across "opportunistic aerosol transmission" - I can't remember who described the overdispersion of

Megan L. Srinivas, MD MPH

Let’s talk about herd immunity! A thread...(1/8) Herd immunity a type of protection that happens when enough people in a population are immune to an infectious disease, like the influenza

1/N Our new article published in Clinical Infectious Diseases (@IDSAInfo) on role of routine asymptomatic testing for #COVID19 in healthcare settings. We find twice weekly testing of all healthcare workers/patients

Kartik Cherabuddi, MD, FACP

15 Reasons to NOT wear a face mask. From an Infectious diseases specialist and epidemiologist. 1. You are in your bathroom2. You are in your bedroom3. You are walking from

We’re excited to highlight @SIDPharm Member presentations at #IDWeek2020 in this thread! Click the link to visit the @IDWeek2020 website & add presentations to your schedule by clicking the

Prathit Kulkarni, MD

PrathitKulkarni

(1/7) A framework for understanding post-acute #COVID19 / #LongCOVID https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaa509/5934556#IDtwitter #MedTwitter #publichealth #publichealthtwitter (2/7) Post-acute #COVID19 can be di

Jonathan Ryder, MD

JonathanRyderMD

1/ While on my current GI rotation, I've been reading about Clostridioides difficile because, you know, #IDNerd. I ran across something I had not learned about before:A Hypervirulent Strain of

IDSA Medical Education Community of Practice

How can we promote academic advancement for JR faculty? Finding the right mentorship is key. Check out #IDWeek2020 oral abstract 134 by @vera_luther @armstrws @BonuraErin @MikeMeliaMD @DrDavidRiedel @BSchwartzinSF This abstract